Cardiol Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRDL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Dec 24	BuyUS$21,721	Guillermo Torre-Amione	Individual	17,240	US$1.26
19 Dec 24	BuyUS$24,727	Andrew Hamer	Individual	18,900	US$1.31
18 Dec 24	BuyUS$28,333	Guillermo Torre-Amione	Individual	21,548	US$1.45
17 Dec 24	BuyUS$13,617	Bernard Lim	Individual	10,000	US$1.36
17 Dec 24	BuyUS$49,968	Peter Pekos	Individual	38,750	US$1.29
16 Dec 24	BuyUS$52,741	David Elsley	Individual	40,000	US$1.32
16 Dec 24	BuyUS$34,918	Christopher Waddick	Individual	25,900	US$1.35

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRDL?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	15,005	0.0179%
Individual Insiders	3,034,862	3.62%
Institutions	6,736,541	8.05%
General Public	73,943,040	88.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.8%.

Top Shareholders

Top 25 shareholders own 11.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.9%	Tejara Capital Limited., Asset Management Arm	3,265,819	US$3.8m	2.22%	1.78%
1.49%	David Elsley	1,244,500	US$1.4m	0%	no data
1.02%	AdvisorShares Investments, LLC	857,388	US$986.6k	-12.7%	0.16%
0.6%	Peter Pekos	506,040	US$582.3k	0%	no data
0.56%	Andrew Hamer	466,613	US$537.0k	0%	no data
0.52%	PVG Asset Management Corp	437,362	US$503.3k	0%	2.17%
0.41%	Lion Street Advisors, LLC	340,025	US$391.3k	1.89%	0.12%
0.35%	MM Asset Management Inc	293,056	US$337.2k	-62.6%	0.03%
0.31%	Guillermo Torre-Amione	259,309	US$298.4k	0%	no data
0.25%	Cambridge Investment Research Advisors, Inc.	206,265	US$237.4k	-35.8%	no data
0.22%	Envestnet Asset Management, Inc.	181,682	US$209.1k	-44.8%	no data
0.17%	Colin Stott	142,500	US$164.0k	0%	no data
0.17%	UBS Asset Management AG	139,244	US$160.2k	-74.8%	no data
0.16%	Christopher Waddick	135,900	US$156.4k	0%	no data
0.14%	Jennifer Chao	120,000	US$138.1k	20%	no data
0.14%	Teri Loxam	120,000	US$138.1k	0%	no data
0.12%	Knoll Capital Management	100,000	US$115.1k	0%	0.08%
0.12%	MGO One Seven LLC	100,000	US$115.1k	0%	no data
0.12%	Morgan Stanley, Investment Banking and Brokerage Investments	99,881	US$114.9k	67.6%	no data
0.12%	Atria Investments, Inc.	96,342	US$110.9k	-30.7%	no data
0.072%	Cetera Investment Advisers LLC	59,952	US$69.0k	-11.3%	no data
0.069%	Goldman Sachs Group, Investment Banking and Securities Investments	57,500	US$66.2k	46.7%	no data
0.066%	PMG Investment Solutions AG	55,000	US$63.3k	0%	0.03%
0.063%	Geode Capital Management, LLC	52,435	US$60.3k	0%	no data
0.06%	BMO Asset Management Corp.	50,000	US$57.5k	-0.16%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/08/21 18:45
End of Day Share Price	2025/08/21 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cardiol Therapeutics Inc. is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Nash	Canaccord Genuity
Christian Orquera	First Berlin Equity Research GmbH
Vernon Bernardino	H.C. Wainwright & Co.